# Individualized Goal-directed Sufentanil Administration Versus Standard Therapy in Patients Undergoing Major Abdominal Surgery

> **NCT03166644** · NA · COMPLETED · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 128 (actual)

## Conditions studied

- Major Abdominal Surgery

## Interventions

- **DEVICE:** Analgesia Nociception Index (ANI)-guided sufentanil administration

## Key facts

- **NCT ID:** NCT03166644
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-04
- **Primary completion:** 2019-01-20
- **Final completion:** 2019-01-20
- **Target enrollment:** 128 (ACTUAL)
- **Last updated:** 2023-10-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03166644

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03166644, "Individualized Goal-directed Sufentanil Administration Versus Standard Therapy in Patients Undergoing Major Abdominal Surgery". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03166644. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*